EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib

Laura V Ashton iD, Barbara Graham iD, Maryam F Afzali, Daniel Gustafson, Amy L MacNeill iD

Oncolytic Virotherapy · 2020

DOI: 10.2147/ov.s252727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncolytic Virotherapy, 2020. Verfasst von Laura V Ashton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collin…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Janus kinase inhibitoroncolytic viruspoxvirussarcoma

Autor:innen und Institutionen

  • Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
  • Departiment of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.

ORCID-Profile: Laura V Ashton, Barbara Graham, Amy L MacNeill

Zitieren

APA

Ashton, L. V., Graham, B., Afzali, M. F., Gustafson, D., & MacNeill, A. L. (2020). Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. Oncolytic Virotherapy. https://doi.org/10.2147/ov.s252727

Vancouver

Ashton LV, Graham B, Afzali MF, Gustafson D, MacNeill AL. Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. Oncolytic Virotherapy. 2020. doi:10.2147/ov.s252727

BibTeX
@article{Ashton2020,
  author = {Ashton, Laura V and Graham, Barbara and Afzali, Maryam F and Gustafson, Daniel and MacNeill, Amy L},
  title = {Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib},
  journal = {Oncolytic Virotherapy},
  year = {2020},
  doi = {10.2147/ov.s252727}
}
Kostenlos starten →